Company Filing History:
1 out of 44 
1 out of 15 Years Active: 2016
Title: Annett Müller: Innovator in Cancer Treatment
Introduction: Annett Müller is a prominent inventor based in Griesheim, Germany. With one notable patent to her name, she has made significant strides in the field of cancer treatment, particularly in targeting colorectal and gastric adenocarcinoma. Her innovative work showcases the intersection of medicinal chemistry and clinical pharmacology.
Latest Patents: Annett Müller holds a patent for "3-(indolyl)- or 3-(azaindolyl)-4-arylmaleimide derivatives for use in the treatment of colon and gastric adenocarcinoma." This invention is centered around a compound formula (I), which includes specific configurations of phenyl groups that are substituted with 2 or 3 C-Calkoxy groups. This patented compound aims to provide effective treatment options for patients suffering from these types of cancers, contributing to advancements in therapeutic methodologies.
Career Highlights: Annett Muller has had a distinguished career, with her work primarily associated with prestigious institutions such as Johannes Gutenberg University Mainz and Universitätsmedizin der Johannes Gutenberg-Universität Mainz. Her experience in these renowned organizations has greatly enhanced her research capabilities and allowed her to focus her efforts on creating impactful medicinal compounds.
Collaborations: Throughout her career, Annett has collaborated with esteemed colleagues such as Gerd Dannhardt and Stanislav Plutizki. These collaborations not only highlight her ability to work effectively within teams but also underscore the importance of interdisciplinary research in achieving significant breakthroughs in medical science.
Conclusion: Annett Müller exemplifies the tireless pursuit of innovation in the medical field. Through her patent and collaborative efforts, she continues to make meaningful contributions towards the treatment of devastating illnesses like colorectal and gastric adenocarcinoma. Her work stands as a testament to the role of inventors in shaping the future of healthcare.